The global Genomic Medicine market size in 2023 is 31356.0 million US dollars, and it is expected to be 94106.9 million US dollars by 2030, with a compound annual growth rate of 17.0% expected in 2024-2030.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Genomic Medicine market include Genome Medical, Inc., BioMed Central Ltd, Aevi Genomic Medicine, Inc., Congenica Ltd., and Deep Genomics. The share of the top 3 players in the Genomic Medicine market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Genomic Medicine market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Oncology accounted for XX% of Genomic Medicine market in 2023. Cardiology share of XX%.
Hospitals & Clinics accounted for XX% of the Genomic Medicine market in 2023. Academic Institutions accounts for XX%.

This Genomic Medicine market report provides detailed information on latest developments, trade regulations, value chain optimization, market share, impact of domestic and local market players, analyzes emerging revenue sources, market regulation changes Opportunities in Aspects, Strategic Market Growth Analysis, Market Size, Category Market Growth, Application Areas and Dominance, Product Approvals, Product Launches, Geographic Expansion, Technological Innovations in the Market.

Genomic Medicine market country level analysis
The countries covered in the Genomic Medicine market report include the United States, Canada, Germany, United Kingdom, France, Russia, Japan, China, India, South Korea, Brazil, UAE, Saudi Arabia, etc.
The presence and availability of global brands and challenges due to intense or scarce competition from local and domestic brands, and trade routes are also considered while providing the predictive analysis of country data.

Competitive Landscape and Genomic Medicine Market Share Analysis
Genomic Medicine market competitive landscape provides details by competitors. The detailed information includes company profile, company financials, revenue generated, market potential, R&D investments, new market plans, global reach. The data points presented above relate only to companies relevant to the Genomic Medicine market.

Chapter Outline
Chapter 1: Introduces the product overview, market scope, economic analysis of global regions, and industry dynamic analysis, and then includes inflation analysis, the impact of the Russo-Ukrainian war on the market, and the global impact of the coronavirus disease (COVID-19).
Chapter 2: Analyzes the main companies in the Genomic Medicine industry, including their main businesses, products/services, revenue, gross margin, and SWOT Analysis.
Chapter 3: Analysis of the competitive environment of Genomic Medicine market participants. This mainly includes the revenue and market share of the top players, along with the players” M&A and new entrants and expansion plans.
Chapters 4-6: Segmented the global Genomic Medicine market by type, application and region. Analyze the revenue of market segments from different perspectives.
Chapters 7-11: Provide North America, Europe, Asia-Pacific, Latin America and Middle East & Africa Genomic Medicine market type, application, country and player market segmentation data, and include SWOT Analysis.
Chapter 12: Analyzes the Genomic Medicine business cost, including industrial chain and the proportion of business cost structure.
Chapter 13: The main points and conclusions of the report.
Chapter 14: Concludes with an explanation of the data sources and research methods.

Highlights-Regions

North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Nordic
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
South America
Brazil
Argentina
MEA
Saudi Arabia
Egypt
Turkey
UAE
South Africa

Player list
Genome Medical, Inc.
BioMed Central Ltd
Aevi Genomic Medicine, Inc.
Congenica Ltd.
Deep Genomics
Editas Medicine
Cleveland Clinic
Illumina, Inc.
Thermo Fisher Scientific Inc.
Other Key Players

Types list
Oncology
Cardiology
Pediatrics

Application list
Hospitals & Clinics
Academic Institutions
Research Institutions

Table of Content

1 Market Overview
1.1 Genomic Medicine Introduction
1.2 Market Analysis by Types
1.3 Market Analysis by Applications
1.4 Global Genomic Medicine Market Size & Forecast
1.4.1 Global Genomic Medicine Revenue (2019 VS 2023 VS 2030)
1.4.2 Global Genomic Medicine Revenue in Value (2019-2030)
1.5 Market Drivers, Restraints and Trends
1.5.1 Genomic Medicine Market Drivers
1.5.2 Genomic Medicine Market Restraints
1.5.3 Genomic Medicine Trends Analysis
1.6 Economic Analysis of Global Regions
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Manufacturers Profiles
2.1 Genome Medical, Inc.
2.1.1 Business Overview
2.1.2 Genome Medical, Inc. SWOT Analysis
2.1.3 Genome Medical, Inc. Genomic Medicine Products and Service Offered
2.1.4 Genome Medical, Inc. Genomic Medicine Revenue and Gross Margin
2.2 BioMed Central Ltd
2.2.1 Business Overview
2.2.2 BioMed Central Ltd SWOT Analysis
2.2.3 BioMed Central Ltd Genomic Medicine Products and Service Offered
2.2.4 BioMed Central Ltd Genomic Medicine Revenue and Gross Margin
2.3 Aevi Genomic Medicine, Inc.
2.3.1 Business Overview
2.3.2 Aevi Genomic Medicine, Inc. SWOT Analysis
2.3.3 Aevi Genomic Medicine, Inc. Genomic Medicine Products and Service Offered
2.3.4 Aevi Genomic Medicine, Inc. Genomic Medicine Revenue and Gross Margin
2.4 Congenica Ltd.
2.4.1 Business Overview
2.4.2 Congenica Ltd. SWOT Analysis
2.4.3 Congenica Ltd. Genomic Medicine Products and Service Offered
2.4.4 Congenica Ltd. Genomic Medicine Revenue and Gross Margin
2.5 Deep Genomics
2.5.1 Business Overview
2.5.2 Deep Genomics SWOT Analysis
2.5.3 Deep Genomics Genomic Medicine Products and Service Offered
2.5.4 Deep Genomics Genomic Medicine Revenue and Gross Margin
2.6 Editas Medicine
2.6.1 Business Overview
2.6.2 Editas Medicine SWOT Analysis
2.6.3 Editas Medicine Genomic Medicine Products and Service Offered
2.6.4 Editas Medicine Genomic Medicine Revenue and Gross Margin
2.7 Cleveland Clinic
2.7.1 Business Overview
2.7.2 Cleveland Clinic SWOT Analysis
2.7.3 Cleveland Clinic Genomic Medicine Products and Service Offered
2.7.4 Cleveland Clinic Genomic Medicine Revenue and Gross Margin
2.8 Illumina, Inc.
2.8.1 Business Overview
2.8.2 Illumina, Inc. SWOT Analysis
2.8.3 Illumina, Inc. Genomic Medicine Products and Service Offered
2.8.4 Illumina, Inc. Genomic Medicine Revenue and Gross Margin
2.9 Thermo Fisher Scientific Inc.
2.9.1 Business Overview
2.9.2 Thermo Fisher Scientific Inc. SWOT Analysis
2.9.3 Thermo Fisher Scientific Inc. Genomic Medicine Products and Service Offered
2.9.4 Thermo Fisher Scientific Inc. Genomic Medicine Revenue and Gross Margin
2.10 Other Key Players
2.10.1 Business Overview
2.10.2 Other Key Players SWOT Analysis
2.10.3 Other Key Players Genomic Medicine Products and Service Offered
2.10.4 Other Key Players Genomic Medicine Revenue and Gross Margin
3 Global Genomic Medicine Market Competition, by Manufacturer
3.1 Global Genomic Medicine Revenue and Market Share by Manufacturer
3.2 Market Concentration Rate
3.2.1 Top 3 Genomic Medicine Players Market Share in 2023
3.2.2 Top 6 Genomic Medicine Players Market Share in 2023
3.2.3 Market Competition Trend
3.3 Genomic Medicine Players Head Office, Business Provided
3.4 Genomic Medicine Mergers & Acquisitions
3.5 Genomic Medicine New Entrants and Expansion Plans
4 Market Segment by Type
4.1 Global Genomic Medicine Revenue in Value by Type (2019-2030)
4.2 Global Genomic Medicine Revenue Share by Type (2019-2030)
5 Market Segment by Application
5.1 Global Genomic Medicine Revenue by Application (2019-2030)
5.2 Global Genomic Medicine Revenue Share by Application (2019-2030)
6 Global Genomic Medicine Market Analysis by Regions
6.1 Global Genomic Medicine Revenue and Market Share by Regions
6.1.1 Global Genomic Medicine Revenue by Regions (2019-2030)
6.1.2 Global Genomic Medicine Revenue Market Share by Regions (2019-2030)
6.2 North America Genomic Medicine Revenue and Growth (2019-2030)
6.3 Europe Genomic Medicine Revenue and Growth (2019-2030)
6.4 Asia Pacific Genomic Medicine Revenue and Growth (2019-2030)
6.5 South America Genomic Medicine Revenue and Growth (2019-2030)
6.6 Middle East and Africa Genomic Medicine Revenue and Growth (2019-2030)
7 North America Genomic Medicine by Country, by Type, and by Application
7.1 North America Genomic Medicine Revenue by Type (2019-2030)
7.2 North America Genomic Medicine Revenue by Application (2019-2030)
7.3 North America Genomic Medicine Revenue and Market Share by Countries
7.3.1 North America Genomic Medicine Revenue in Value by Country (2019-2030)
7.3.2 United States Genomic Medicine Revenue and Growth (2019-2030)
7.3.3 Canada Genomic Medicine Revenue and Growth (2019-2030)
7.3.4 Mexico Genomic Medicine Revenue and Growth (2019-2030)
7.4 North America SWOT Analysis
8 Europe Genomic Medicine by Country, by Type, and by Application
8.1 Europe Genomic Medicine Revenue by Type (2019-2030)
8.2 Europe Genomic Medicine Revenue by Application (2019-2030)
8.3 Europe Genomic Medicine Revenue and Market Share by Countries
8.3.1 Europe Genomic Medicine Revenue in Value by Country (2019-2030)
8.3.2 Germany Genomic Medicine Revenue and Growth (2019-2030)
8.3.3 France Genomic Medicine Revenue and Growth (2019-2030)
8.3.4 United Kingdom Genomic Medicine Revenue and Growth (2019-2030)
8.3.5 Russia Genomic Medicine Revenue and Growth (2019-2030)
8.3.6 Italy Genomic Medicine Revenue and Growth (2019-2030)
8.3.7 Nordic Genomic Medicine Revenue and Growth (2019-2030)
8.4 Europe SWOT Analysis
9 Asia Pacific Genomic Medicine by Country, by Type, and by Application
9.1 Asia Pacific Genomic Medicine Revenue by Type (2019-2030)
9.2 Asia Pacific Genomic Medicine Revenue by Application (2019-2030)
9.3 Asia Pacific Genomic Medicine Revenue and Market Share by Countries
9.3.1 Asia Pacific Genomic Medicine Revenue in Value by Country (2019-2030)
9.3.2 China Genomic Medicine Revenue and Growth (2019-2030)
9.3.3 Japan Genomic Medicine Revenue and Growth (2019-2030)
9.3.4 Korea Genomic Medicine Revenue and Growth (2019-2030)
9.3.5 India Genomic Medicine Revenue and Growth (2019-2030)
9.3.6 Southeast Asia Genomic Medicine Revenue and Growth (2019-2030)
9.3.7 Australia Genomic Medicine Revenue and Growth (2019-2030)
9.4 Asia Pacific SWOT Analysis
10 South America Genomic Medicine by Country, by Type, and by Application
10.1 South America Genomic Medicine Revenue by Type (2019-2030)
10.2 South America Genomic Medicine Revenue by Application (2019-2030)
10.3 South America Genomic Medicine Revenue and Market Share by Countries
10.3.1 South America Genomic Medicine Revenue in Value by Country (2019-2030)
10.3.2 Brazil Genomic Medicine Revenue and Growth (2019-2030)
10.3.3 Argentina Genomic Medicine Revenue and Growth (2019-2030)
10.4 South America SWOT Analysis
11 Middle East & Africa Genomic Medicine by Country, by Type, and by Application
11.1 Middle East & Africa Genomic Medicine Revenue by Type (2019-2030)
11.2 Middle East & Africa Genomic Medicine Revenue by Application (2019-2030)
11.3 Middle East & Africa Genomic Medicine Revenue and Market Share by Countries
11.3.1 Middle East & Africa Genomic Medicine Revenue in Value by Country (2019-2030)
11.3.2 Turkey Genomic Medicine Revenue and Growth (2019-2030)
11.3.3 Egypt Genomic Medicine Revenue and Growth (2019-2030)
11.3.4 Saudi Arabia Genomic Medicine Revenue and Growth (2019-2030)
11.3.5 UAE Genomic Medicine Revenue and Growth (2019-2030)
11.3.6 South Africa Genomic Medicine Revenue and Growth (2019-2030)
11.4 Middle East and Africa SWOT Analysis
12 Genomic Medicine Business Cost Analysis
12.1 Proportion of Business Cost Structure
12.1.1 Labor Cost
12.1.2 Operating Expenses
12.2 Genomic Medicine Industrial Chain Analysis
13 Research Findings and Conclusion
14 Methodology and Data Source
14.1 A Methodology
14.1.1 Research Process
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 B Data Source
14.2.1 Legal Disclaimer

List of Tables and Figures

Figure Genomic Medicine Picture
Table Product Specifications of Genomic Medicine
Figure Global Revenue Market Share of Genomic Medicine by Types in 2023
Table Types of Genomic Medicine
Figure Genomic Medicine Market Share by Applications in 2023
Table Application of Genomic Medicine
Figure Global Genomic Medicine Revenue (2019 VS 2023 VS 2030)
Figure Global Genomic Medicine Revenue in Value (2019-2030)
Table Economic Analysis of Global Regions
Table Inflation Analysis
Table The Impact of the Russian-Ukrainian War on the Market
Figure 2020 (COVID-19) Impact on Global Economic Growth 2019, 2020, 2021
Figure Population infected by the Covid-19 of Major Countries
Table Genome Medical, Inc. Details
Table SWOT Analysis
Table Genome Medical, Inc. Genomic Medicine Revenue and Gross Margin (2019-2024)
Figure Genome Medical, Inc. Revenue Market Share 2019-2024
Table BioMed Central Ltd Details
Table SWOT Analysis
Table BioMed Central Ltd Genomic Medicine Revenue and Gross Margin (2019-2024)
Figure BioMed Central Ltd Revenue Market Share 2019-2024
Table Aevi Genomic Medicine, Inc. Details
Table SWOT Analysis
Table Aevi Genomic Medicine, Inc. Genomic Medicine Revenue and Gross Margin (2019-2024)
Figure Aevi Genomic Medicine, Inc. Revenue Market Share 2019-2024
Table Congenica Ltd. Details
Table SWOT Analysis
Table Congenica Ltd. Genomic Medicine Revenue and Gross Margin (2019-2024)
Figure Congenica Ltd. Revenue Market Share 2019-2024
Table Deep Genomics Details
Table SWOT Analysis
Table Deep Genomics Genomic Medicine Revenue and Gross Margin (2019-2024)
Figure Deep Genomics Revenue Market Share 2019-2024
Table Editas Medicine Details
Table SWOT Analysis
Table Editas Medicine Genomic Medicine Revenue and Gross Margin (2019-2024)
Figure Editas Medicine Revenue Market Share 2019-2024
Table Cleveland Clinic Details
Table SWOT Analysis
Table Cleveland Clinic Genomic Medicine Revenue and Gross Margin (2019-2024)
Figure Cleveland Clinic Revenue Market Share 2019-2024
Table Illumina, Inc. Details
Table SWOT Analysis
Table Illumina, Inc. Genomic Medicine Revenue and Gross Margin (2019-2024)
Figure Illumina, Inc. Revenue Market Share 2019-2024
Table Thermo Fisher Scientific Inc. Details
Table SWOT Analysis
Table Thermo Fisher Scientific Inc. Genomic Medicine Revenue and Gross Margin (2019-2024)
Figure Thermo Fisher Scientific Inc. Revenue Market Share 2019-2024
Table Other Key Players Details
Table SWOT Analysis
Table Other Key Players Genomic Medicine Revenue and Gross Margin (2019-2024)
Figure Other Key Players Revenue Market Share 2019-2024
Table Global Genomic Medicine Revenue by Manufacturer (2019-2024)
Figure Global Genomic Medicine Revenue Market Share by Manufacturer in 2023
Figure Global Top 3 Companies Revenue Share in 2023
Figure Global Top 6 Companies Revenue Share in 2023
Table Global Genomic Medicine Manufacturers Market Concentration Ratio (CR5) (2019-2024)
Table Genomic Medicine Players Head Office, Business Provided
Table Mergers & Acquisitions
Table New Entrants and Expansion Plans
Table Global Genomic Medicine Revenue in Value by Type (2019-2030)
Table Global Genomic Medicine Revenue Share by Type (2019-2030)
Table Global Genomic Medicine Revenue by Application (2019-2030)
Table Global Genomic Medicine Revenue Share by Application (2019-2030)
Figure Global Genomic Medicine Revenue and Growth (2019-2030)
Table Global Genomic Medicine Revenue by Regions (2019-2030)
Table Global Genomic Medicine Revenue Market Share by Regions (2019-2030)
Figure North America Genomic Medicine Revenue and Growth (2019-2030)
Figure Europe Genomic Medicine Revenue and Growth (2019-2030)
Figure Asia Pacific Genomic Medicine Revenue and Growth (2019-2030)
Figure South America Genomic Medicine Revenue and Growth (2019-2030)
Figure Middle East and Africa Genomic Medicine Revenue and Growth (2019-2030)
Table North America Genomic Medicine Revenue by Type (2019-2030)
Table North America Genomic Medicine Revenue by Application (2019-2030)
Table North America Genomic Medicine Revenue by Countries (2019-2030)
Table North America Genomic Medicine Revenue Market Share by Countries (2019-2030)
Figure United States Genomic Medicine Revenue and Growth (2019-2030)
Figure Canada Genomic Medicine Revenue and Growth (2019-2030)
Figure Mexico Genomic Medicine Revenue and Growth (2019-2030)
Table SWOT Analysis
Table Europe Genomic Medicine Revenue by Type (2019-2030)
Table Europe Genomic Medicine Revenue by Application (2019-2030)
Table Europe Genomic Medicine Revenue by Countries (2019-2030)
Table Europe Genomic Medicine Revenue Market Share by Countries (2019-2030)
Figure Germany Genomic Medicine Revenue and Growth (2019-2030)
Figure France Genomic Medicine Revenue and Growth (2019-2030)
Figure United Kingdom Genomic Medicine Revenue and Growth (2019-2030)
Figure Russia Genomic Medicine Revenue and Growth (2019-2030)
Figure Italy Genomic Medicine Revenue and Growth (2019-2030)
Figure Nordic Genomic Medicine Revenue and Growth (2019-2030)
Table SWOT Analysis
Table Asia Pacific Genomic Medicine Revenue by Type (2019-2030)
Table Asia Pacific Genomic Medicine Revenue by Application (2019-2030)
Table Asia Pacific Genomic Medicine Revenue by Countries (2019-2030)
Table Asia Pacific Genomic Medicine Revenue Market Share by Countries (2019-2030)
Figure China Genomic Medicine Revenue and Growth (2019-2030)
Figure Japan Genomic Medicine Revenue and Growth (2019-2030)
Figure Korea Genomic Medicine Revenue and Growth (2019-2030)
Figure India Genomic Medicine Revenue and Growth (2019-2030)
Figure Southeast Asia Genomic Medicine Revenue and Growth (2019-2030)
Figure Australia Genomic Medicine Revenue and Growth (2019-2030)
Table SWOT Analysis
Table South America Genomic Medicine Revenue by Type (2019-2030)
Table South America Genomic Medicine Revenue by Application (2019-2030)
Table South America Genomic Medicine Revenue by Countries (2019-2030)
Table South America Genomic Medicine Revenue Market Share by Countries (2019-2030)
Figure Brazil Genomic Medicine Revenue and Growth (2019-2030)
Figure Argentina Genomic Medicine Revenue and Growth (2019-2030)
Table SWOT Analysis
Table Middle East & Africa Genomic Medicine Revenue by Type (2019-2030)
Table Middle East & Africa Genomic Medicine Revenue by Application (2019-2030)
Table Middle East & Africa Genomic Medicine Revenue by Countries (2019-2030)
Table Middle East & Africa Genomic Medicine Revenue Market Share by Countries (2019-2030)
Figure Turkey Genomic Medicine Revenue and Growth (2019-2030)
Figure Egypt Genomic Medicine Revenue and Growth (2019-2030)
Figure Saudi Arabia Genomic Medicine Revenue and Growth (2019-2030)
Figure UAE Genomic Medicine Revenue and Growth (2019-2030)
Figure South Africa Genomic Medicine Revenue and Growth (2019-2030)
Table SWOT Analysis
Figure Proportion of Business Cost Structure
Table Labor Cost Analysis
Table Operating Expenses Analysis
Figure Genomic Medicine Industrial Chain Analysis
Table Research Process
Figure Bottom-up and Top-down Approaches for This Report